Evidence map›Paper›PMID 36051618›Full record

ArticleAmerican journal of clinical and experimental urology2022

Racial disparities in biochemical recurrence of prostate cancer.

Karishma Gupta, Vidushri Mehrotra, Pingfu Fu, Kyle Scarberry, Gregory T MacLennan, Sanjay Gupta

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of clinical and experimental urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Journal of racial and ethnic health disparities · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karishma GuptaUrology Institute, University Hospitals Cleveland Medical Center Cleveland, Ohio 44106, USA.
Vidushri MehrotraCollege of Arts and Sciences, Case Western Reserve University Cleveland, Ohio 44106, USA.
Pingfu FuDepartment of Population and Quantitative Health Sciences, Case Western Reserve University Cleveland, Ohio 44106, USA.
Kyle ScarberryUrology Institute, University Hospitals Cleveland Medical Center Cleveland, Ohio 44106, USA.
Gregory T MacLennanDepartment of Pathology, Case Western Reserve University School of Medicine Cleveland, Ohio 44106, USA.
Sanjay GuptaUrology Institute, University Hospitals Cleveland Medical Center Cleveland, Ohio 44106, USA.
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

BLRD VA I01 BX002494
6 · The paper itself

Abstract

backgroundThe aim of this study was to determine the biochemical recurrence among Black and White American men with grade group 2-5 prostate cancer managed primarily by radical prostatectomy (RP).

methodsThis was a single-institution, retrospective study evaluating biochemical recurrence by self-identified race. 163 patients who underwent RP at the University Hospitals Cleveland Medical Center between 2015-2021 were analyzed for racial differences in age at diagnosis, clinical stage, and preoperative serum prostate-specific antigen (PSA). Patients were followed for PSA recurrence (PSA ≥ 0.2 ng/ml). Multivariate analysis was used to determine clinical and pathologic variables that were significant in predicting biochemical recurrence after RP and to determine whether race was an independent predictor of biochemical recurrence-free survival (BCRFS).

resultsOf 163 patients, 82 (50.3%) were Black Americans and 81 (49.7%) were White Americans with a median age of 62.7 ranging between 38.7 to 76.3 years. The grade-specific distribution of cancer 3+4 was 54.9%

conclusionOur study demonstrated a significant difference in BCRFS between Black and White American patients. Additional studies with larger sample size underlying this clinical disparity are warranted.

Indexed as

biochemical recurrencegleason scoreprostate cancerprostate-specific antigenRacial difference

Identifiers

PMID36051618
PMCPMC9428572
OpenAlexW4294355821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.